Case report: A brief description of unseen facts in the comorbid
AbstractData on two deceased individuals with COVID-19 and comorbidities such as
hepatitis C, chronic kidney disease, diabetes mellitus type 2 and
hypertension are discussed. Changes in laboratory signatures with impact
on COVID-19 severity in both cases indicate the need for extensive
monitoring of comorbid individuals to reduce morbidity and mortality.